Evidence map›Paper›PMID 31604441›Full record

ArticleJournal of nanobiotechnology2019

Yanshu Wang, Huanhuan Liu, Defan Yao, Jinning Li, Shuyan Yang, Caiyuan Zhang, Weibo Chen, Dengbin Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. [Molecules (Basel, Switzerland) · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Nanotechnology-Assisted Cell Tracking.Nanomaterials (Basel, Switzerland) · 2022
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yanshu WangDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Huanhuan LiuDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Defan YaoDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Jinning LiDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Shuyan YangDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Caiyuan ZhangDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Weibo ChenPhilips Healthcare, Shanghai, 200233, China.
Dengbin WangDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China. wangdengbin@xinhuamed.com.cn.
Shanghai Jiao Tong University · CNXinHua Hospital · CNPhilips (China) · CN

Funding

National Natural Science Foundation of China NSFC 81371621Shanghai Shen Kang Hospital Development Center SHDC 22015022
6 · The paper itself

Abstract

purposeTo develop a novel fluorine-18 (

methodsThe RGD peptide and

resultsExcellent stability, low toxicity, and good specificity to endothelial of

conclusionPET/MRI with the dual-modality nanoprobe,

Indexed as

Angiogenesis InhibitorsAnimalsBreast NeoplasmsCell Line, TumorDextransFemaleFluorine RadioisotopesHumansMagnetic Resonance ImagingMagnetite NanoparticlesMiceMice, Inbred BALB CMice, NudeOligopeptidesPositron-Emission TomographyAngiogenesis Inhibitorsarginyl-glycyl-aspartic acidDextransferumoxtran-10Fluorine-18Fluorine RadioisotopesMagnetite NanoparticlesOligopeptidesAnti-angiogenesis therapyBreast cancerDual modalityPET/MRIαvβ3-integrin

Identifiers

PMID31604441
PMCPMC6788012
OpenAlexW2979423683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.